Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.

Annals of Medicine
Harsh GoelGregory Y H Lip

Abstract

Cardiac troponins (cTn) are currently the standard of care for the diagnosis of acute coronary syndromes (ACS) in patients presenting to the emergency department (ED) with chest pain (CP). However, their plasma kinetics necessitate a prolonged ED stay or overnight hospital admission, especially in those presenting early after CP onset. Moreover, ruling out ACS in low-risk patients requires prolonged ED observation or overnight hospital admission to allow serial measurements of c-Tn, adding cost. Heart-type fatty acid-binding protein (H-FABP) is a novel marker of myocardial injury with putative advantages over cTn. Being present in abundance in the myocellular cytoplasm, it is released rapidly (<1 h) after the onset of myocardial injury and could potentially play an important role in both earlier diagnosis of high-risk patients presenting early after CP onset, as well as in risk-stratifying low-risk patients rapidly. Like cTn, H-FABP also has a potential role as a prognostic marker in other conditions where the myocardial injury occurs, such as acute congestive heart failure (CHF) and acute pulmonary embolism (PE). This review provides an overview of the evidence examining the role of H-FABP in early diagnosis and risk stratific...Continue Reading

References

Oct 21, 1992·Molecular and Cellular Biochemistry·A H KleineG J Van der Vusse
Feb 1, 1995·Histochemistry and Cell Biology·W ZschiescheJ F Glatz
Dec 1, 1996·Clinical Biochemistry·J P BertinchantB Pau
Jan 1, 1997·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J F TuckerF S Apple
Jan 16, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J F GlatzG J van der Vusse
May 15, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·J F GlatzW T Hermens
Apr 20, 2000·The New England Journal of Medicine·J H PopeH P Selker
Oct 29, 2003·Molecular & Cellular Proteomics : MCP·Catherine G Zimmermann-IvolJean-Charles Sanchez
Jan 28, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Yoshihiko SeinoUNKNOWN Tokyo Rapid-Test Office Cardiologists (Tokyo-ROC) Study
Feb 21, 2004·Journal of the American College of Cardiology·Damien LogeartAlain Cohen Solal
Apr 16, 2004·Journal of Rehabilitation Medicine·Jörgen BorgUNKNOWN WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury
Jan 18, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Maurice M A L PelsersJan F C Glatz
Apr 19, 2005·Journal of Neurology·Michael T WunderlichMaurice M A L Pelsers
Jul 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi NiizekiIsao Kubota
May 16, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Anna KaczyñskaPiotr Pruszczyk
Nov 23, 2006·Annals of Emergency Medicine·Michael J SchullTherese A Stukel
Dec 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi NiizekiIsao Kubota
Mar 26, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Koichi SetsutaKyoichi Mizuno
May 8, 2008·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Hector Alonso ValleLuis Iglesias Oliva
Aug 7, 2008·European Heart Journal·Conor J McCannJennifer A Adgey
Nov 11, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Tuomo IlvaKari Pulkki
Dec 23, 2008·The American Journal of Cardiology·Conor J McCannJennifer A Adgey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.